#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Leiomyosarcoma Hypochromic anaemia Bladder cancer Hypersensitivity pneumonitis B-cell type acute leukaemia Metachromatic leukodystrophy Fragile X syndrome Von Willebrand's disease Oesophageal squamous cell carcinoma stage II Cystic fibrosis Ureteric cancer Arterial tortuosity syndrome Congenital disorder of glycosylation Autoinflammation with infantile enterocolitis Acute myeloid leukaemia (in remission) More trials…

    Learn about Rare Diseases

    Shprintzen-Goldberg syndrome Haemophilia A with anti factor VIII – Trials in Disease Sjogren’s syndrome – Trials in Disease MELAS syndrome – Diagnostics Amyotrophic lateral sclerosis Acquired haemophilia – Treatment Factor VIII deficiency – Treatment Biotinidase deficiency – Trials in Disease Lymphangiosarcoma – Life with Disease Immunodeficiency congenital More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Epirubicin Hydrochloride Batoprotafib Azd0901 Betula Alba Pollen Extract CARBACHOL Aspergillus Fumigatus Sepiapterin Izaflortaucipir (18F) CAL101 Obefazimod Tasipimidine Dalbavancin Streptococcus Pneumoniae Abiraterone Acetate Valaciclovir Pentosan Polysulfate Sodium TUB-030 Labetalol Hydrochloride Mrna-3210 Polatuzumab Vedotin More therapies…

    Learn about Your Condition

    Polycystic ovarian syndrome Hydrocele Castleman's disease Candida infection Sinusitis bacterial Periodontitis Hysterectomy Neonatal anoxia Tinnitus Juvenile idiopathic arthritis Adenovirus infection Pancreatitis acute Dementia Alzheimer's type Cortisol abnormal Heparin resistance More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cataract

  • Comparing the effectiveness of nepafenac and dexamethasone sodium phosphate for treating eye inflammation after cataract surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cataract
    Investigated Drugs:
    • Tobramycin
    • Nepafenac
    • Dexamethasone Phosphate
    Italy

  • Study of herbal medicine combination and bromazepam for anxiety and pain in patients having eye surgery with retrobulbar anesthesia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cataract
    Investigated Drugs:
    • LUPULI FLOS DRY ALCOHOLIC EXTRACT
    • TROCKENEXTRAKT AUS PASSIONSBLUMENKRAUT 5-7:1, AUSZUGSMITTEL ETHANOL 60 % (V/V)
    • VALERIAN ROOT TE WITH ETHANOL/ETHANOL WATER
    Austria

  • Study on Reducing Inflammation After Cataract Surgery Using Nepafenac and Dexamethasone for Patients Undergoing Surgery

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Nepafenac
    • Dexamethasone
    Norway

  • Comparison of preservative-free versus preserved dexamethasone and diclofenac eye drops in patients after cataract surgery

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Cataract
    Investigated Drugs:
    • Diclofenac Sodium
    • Dexamethasone Phosphate
    • Dexamethasone
    Belgium

  • Study on the Effect and Safety of Phenylephrine Hydrochloride, Tropicamide, and Lidocaine Hydrochloride in Children with Cataracts Undergoing Surgery

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Cataract
    Investigated Drugs:
    • Phenylephrine Hydrochloride
    • Lidocaine Hydrochloride
    • Tropicamide
    Belgium

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!